UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years

The Journal of pediatrics, 2015-11, Vol.167 (5), p.1081-1088.e1

2015

Volltextzugriff (PDF)

Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study

The lancet respiratory medicine, 2017-02, Vol.5 (2), p.107-118

2017

Volltextzugriff (PDF)

Systematic Review of Blood Biomarkers in Cystic Fibrosis Pulmonary Exacerbations

Chest, 2013-11, Vol.144 (5), p.1659-1670

2013

Volltextzugriff (PDF)

Risk Factors for First Cerebrospinal Fluid Shunt Infection: Findings from a Multi-Center Prospective Cohort Study

The Journal of pediatrics, 2014-06, Vol.164 (6), p.1462-1468.e2

2014

Volltextzugriff (PDF)

LasR Variant Cystic Fibrosis Isolates Reveal an Adaptable Quorum-Sensing Hierarchy in Pseudomonas aeruginosa

mBio, 2016-10, Vol.7 (5)

2016

Volltextzugriff (PDF)

Effect of Azithromycin on Systemic Markers of Inflammation in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa

Chest, 2012-11, Vol.142 (5), p.1259-1266

2012

Volltextzugriff (PDF)

Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis

Pediatric pulmonology, 2012-02, Vol.47 (2), p.125-134

2012

Volltextzugriff (PDF)

Response to letter

Pediatric pulmonology, 2015-01, Vol.50 (1), p.105-105

2015

Volltextzugriff (PDF)

Revision surgeries are associated with significant increased risk of subsequent cerebrospinal fluid shunt infection

The Pediatric infectious disease journal, 2012-06, Vol.31 (6), p.551-556

2012

Volltextzugriff (PDF)

Treatment and microbiology of repeated cerebrospinal fluid shunt infections in children

The Pediatric infectious disease journal, 2011-09, Vol.30 (9), p.731-735

2011

Volltextzugriff (PDF)

Limited effects of azithromycin on the oropharyngeal microbiome in children with CF and early pseudomonas infection

BMC microbiology, 2023-10, Vol.23 (1), p.312-312, Article 312

2023

Volltextzugriff (PDF)

Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis

Pediatric pulmonology, 2013-10, Vol.48 (10), p.943-953

2013

Volltextzugriff (PDF)

Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa

Pediatric pulmonology, 2012-07, Vol.47 (7), p.641-648

2012

Volltextzugriff (PDF)

Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications

American journal of respiratory and critical care medicine, 2020-05, Vol.201 (10), p.1193-1208

2020

Volltextzugriff (PDF)

Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design

BMJ open respiratory research, 2022-06, Vol.9 (1), p.e001289

2022

Volltextzugriff (PDF)

Understanding the Relationship Between Sweat Chloride and Lung Function in Cystic Fibrosis

Chest, 2013-10, Vol.144 (4), p.1418-1418

2013

Volltextzugriff (PDF)

Risk of Post-Lung Transplant Renal Dysfunction in Adults With Cystic Fibrosis

Chest, 2012-07, Vol.142 (1), p.185-191

2012

Volltextzugriff (PDF)

Residual Weighted Learning for Estimating Individualized Treatment Rules

Journal of the American Statistical Association, 2017-01, Vol.112 (517), p.169-187

2017

Volltextzugriff (PDF)

Shifting patterns of inhaled antibiotic use in cystic fibrosis

Pediatric pulmonology, 2008-09, Vol.43 (9), p.874-881

2008

Volltextzugriff (PDF)

Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-ter trial

ERJ open research, 2022-10, Vol.8 (4), p.190

2022

Volltextzugriff (PDF)

Evaluating the predictive ability of sweat chloride

Journal of cystic fibrosis, 2014-01, Vol.13 (1), p.118-118

2014

Volltextzugriff (PDF)

Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis

Pediatric pulmonology, 2007-07, Vol.42 (7), p.610-623

2007

Volltextzugriff (PDF)

Evaluation of microbial bacterial and fungal diversity in cerebrospinal fluid shunt infection

PloS one, 2014-01, Vol.9 (1), p.e83229-e83229

2014

Volltextzugriff (PDF)

Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis

American journal of respiratory and critical care medicine, 2014-07, Vol.190 (2), p.175-184

2014

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(136)

Publikationsform

Sprache

Englisch
(152)

Erscheinungsjahr

n.n

Thema

Science & Technology
(113)
Life Sciences & Biomedicine
(111)
Humans
(102)
Respiratory System
(75)
Cystic Fibrosis
(69)
Female
(61)
Male
(61)
Child
(45)
Biological And Medical Sciences
(39)
Cystic Fibrosis - Drug Therapy
(37)
Medical Sciences
(36)
Adolescent
(34)
General & Internal Medicine
(29)
Adult
(28)
Cystic Fibrosis - Complications
(27)
Critical Care Medicine
(26)
Anti-Bacterial Agents - Therapeutic Use
(23)
Pediatrics
(23)
Treatment Outcome
(23)
Pseudomonas Aeruginosa
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years

Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study

Systematic Review of Blood Biomarkers in Cystic Fibrosis Pulmonary Exacerbations

Risk Factors for First Cerebrospinal Fluid Shunt Infection: Findings from a Multi-Center Prospective Cohort Study

LasR Variant Cystic Fibrosis Isolates Reveal an Adaptable Quorum-Sensing Hierarchy in Pseudomonas aeruginosa

Effect of Azithromycin on Systemic Markers of Inflammation in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa

Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis

Response to letter

Revision surgeries are associated with significant increased risk of subsequent cerebrospinal fluid shunt infection

Treatment and microbiology of repeated cerebrospinal fluid shunt infections in children

Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study

Limited effects of azithromycin on the oropharyngeal microbiome in children with CF and early pseudomonas infection

Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis

Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa

Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications

Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design

Understanding the Relationship Between Sweat Chloride and Lung Function in Cystic Fibrosis

Risk of Post-Lung Transplant Renal Dysfunction in Adults With Cystic Fibrosis

Residual Weighted Learning for Estimating Individualized Treatment Rules

Shifting patterns of inhaled antibiotic use in cystic fibrosis

Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-ter trial

Evaluating the predictive ability of sweat chloride

Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis

Evaluation of microbial bacterial and fungal diversity in cerebrospinal fluid shunt infection

Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis

Suchergebnisse filtern